Zdrowie i gospodarka · 24/07/2026
Government Owned Invention Available for License: Pigment Epithelium-Derived Factor Peptides and Their Use for Treating Retinal Degeneration
The National Eye Institute is seeking partners to co-develop or license a treatment for inherited retinal diseases, utilizing a gene-agnostic approach involving PEDF peptides delivered via an AAV2-based system or eyedrops.